Accelerate Diagnostics (AXDX)
NASDAQ:AXDX
Holding AXDX?
Track your performance easily

Accelerate Diagnostics (AXDX) Financial Statements

297 Followers

Accelerate Diagnostics Financial Overview

Accelerate Diagnostics's market cap is currently ―. The company's EPS TTM is $-2.072; its P/E ratio is -0.96; Accelerate Diagnostics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.47. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.99M$ 2.92M$ 3.03M$ 3.30M$ 2.92M
Gross Profit$ 676.00K$ 723.00K$ 633.00K$ 107.00K$ 799.00K
EBIT$ -11.59M$ -10.56M$ -10.31M$ 3.25M$ -32.58M
EBITDA$ -10.71M$ -9.71M$ -9.49M$ 4.06M$ -31.76M
Net Income Common Stockholders$ -11.59M$ -14.23M$ -12.99M$ 910.00K$ -12.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.75M$ 15.75M$ 13.22M$ 21.15M$ 29.28M
Total Assets$ 22.87M$ 30.72M$ 31.37M$ 39.32M$ 49.88M
Total Debt$ 42.41M$ 40.41M$ 39.22M$ 36.57M$ 36.57M
Net Debt$ 32.66M$ 24.66M$ 26.00M$ 15.42M$ 7.29M
Total Liabilities$ 52.95M$ 56.50M$ 51.25M$ 74.36M$ 88.54M
Stockholders Equity$ -30.11M$ -25.78M$ -19.89M$ -35.03M$ -38.66M
Cash Flow-
Free Cash Flow$ -7.58M$ -8.96M$ -7.87M$ -9.01M$ -10.98M
Operating Cash Flow$ -7.58M$ -8.45M$ -7.75M$ -8.25M$ -10.82M
Investing Cash Flow$ -2.00K$ -513.00K$ -110.00K$ -354.00K$ 915.00K
Financing Cash Flow$ 1.40M$ 11.44M$ 107.00K$ -817.00K$ 9.81M
Currency in USD

Accelerate Diagnostics Earnings and Revenue History

Accelerate Diagnostics Debt to Assets

Accelerate Diagnostics Cash Flow

Accelerate Diagnostics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis